Cargando…

Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics

BACKGROUND: The biomarker fibroblast growth factor-23 (FGF-23) has been associated with increased cardiovascular morbidity and mortality in both patients with and without type 2 diabetes. The aim of this study was to evaluate the relationship between FGF-23 and cardiac structure, function and perfus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sørensen, Martin H., Bojer, Annemie S., Jørgensen, Niklas R., Broadbent, David A., Plein, Sven, Madsen, Per L., Gæde, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528463/ https://www.ncbi.nlm.nih.gov/pubmed/32998751 http://dx.doi.org/10.1186/s12933-020-01135-z

Ejemplares similares

The independent association of myocardial extracellular volume and myocardial blood flow with cardiac diastolic function in patients with type 2 diabetes: a prospective cross-sectional cohort study
por: Bojer, Annemie S., et al.
Publicado: (2023)

Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes
por: Bojer, Annemie Stege, et al.
Publicado: (2020)

Left Ventricular Diastolic Function Studied with Magnetic Resonance Imaging: A Systematic Review of Techniques and Relation to Established Measures of Diastolic Function
por: Bojer, Annemie Stege, et al.
Publicado: (2021)

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats
por: Li, Bingong, et al.
Publicado: (2011)

Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle
por: van den Brom, Charissa E, et al.
Publicado: (2010)

Phenotyping diabetic cardiomyopathy in Europeans and South Asians
por: Paiman, Elisabeth H. M., et al.
Publicado: (2019)

Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model – the Zucker diabetic rat
por: Forcheron, Fabien, et al.
Publicado: (2009)

Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus
por: He, Xingxing, et al.
Publicado: (2017)

Fibroblast Growth Factor 23: Potential Marker of Invisible Heart Damage in Diabetic Population
por: Kurpas, Anna, et al.
Publicado: (2023)

Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes?
por: Kizilgul, Muhammed, et al.
Publicado: (2017)

Riboflavin alleviates cardiac failure in Type I diabetic cardiomyopathy
por: Wang, Guoguang, et al.
Publicado: (2011)

Progressive decay of Ca(2+) homeostasis in the development of diabetic cardiomyopathy
por: Zhao, Shu-Mei, et al.
Publicado: (2014)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy
por: Chung, Yoo-Ri, et al.
Publicado: (2017)

Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy
por: Wen, He-Ling, et al.
Publicado: (2013)

Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways
por: Reinking, Benjamin E, et al.
Publicado: (2009)

Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
por: Arow, M., et al.
Publicado: (2020)

Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid
por: Li, Chun-jun, et al.
Publicado: (2012)

Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline
por: Julián, María Teresa, et al.
Publicado: (2020)

Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice
por: Yan, Xiaoqing, et al.
Publicado: (2015)

Conductance artery stiffness impairs atrio-ventriculo-arterial coupling before manifestation of arterial hypertension or left ventricular hypertrophic remodelling
por: Kyhl, Kasper, et al.
Publicado: (2021)

Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
por: Cheng, Yanan, et al.
Publicado: (2023)

MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin
por: Dai, Beibei, et al.
Publicado: (2018)

Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy
por: Tanaka, Hidekazu, et al.
Publicado: (2020)

Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes
por: Aydın, Kadriye, et al.
Publicado: (2016)

Left Atrial Dysfunction as Marker of Arrhythmic Events in Patients with Hypertrophic Cardiomyopathy
por: Candan, Özkan, et al.
Publicado: (2022)

Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway
por: Korkmaz-Icöz, Sevil, et al.
Publicado: (2016)

Yearly evolution of organ damage markers in diabetes or metabolic syndrome: data from the LOD-DIABETES study
por: Gomez-Marcos, Manuel A, et al.
Publicado: (2011)

Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes
por: Jørgensen, Peter Godsk, et al.
Publicado: (2016)

Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation
por: Zhang, Shaoping, et al.
Publicado: (2014)

Bone markers and cardiovascular risk in type 2 diabetes patients
por: Zwakenberg, Sabine R., et al.
Publicado: (2018)

Left ventricular concentric geometry predicts incident diabetes mellitus independent of established risk factors in the general population: the Copenhagen City Heart Study
por: Modin, Daniel, et al.
Publicado: (2019)

Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes
por: Donate-Correa, Javier, et al.
Publicado: (2021)

Rapid onset of cardiomyopathy in STZ-induced female diabetic mice involves the downregulation of pro-survival Pim-1
por: Moore, Andrew, et al.
Publicado: (2014)

MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα
por: Yin, Zhongwei, et al.
Publicado: (2019)

Incidence of idiopathic cardiomyopathy in patients with type 2 diabetes in Taiwan: age, sex, and urbanization status-stratified analysis
por: Chen, Hua-Fen, et al.
Publicado: (2020)

Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes
por: Swoboda, Peter P., et al.
Publicado: (2018)

Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
por: Xiao, Yang, et al.
Publicado: (2015)

Long‐Term Cardiac Function After Peripartum Cardiomyopathy and Preeclampsia: A Danish Nationwide, Clinical Follow‐Up Study Using Maximal Exercise Testing and Cardiac Magnetic Resonance Imaging
por: Ersbøll, Anne S., et al.
Publicado: (2018)

Effects of granulocyte-colony stimulating factor (G-CSF) on diabetic cardiomyopathy in Otsuka Long-Evans Tokushima Fatty rats
por: Lim, Young-Hyo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hdjrjnpv209l7ublcs2k7v1k5v